$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Hemispherx Biopharma, Inc.
(NYSE Amex Equities : HEB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading HEB News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.39%79.771.3%$810.55m
BIIBBiogen Inc.
0.43%308.171.2%$594.94m
AMGNAmgen Inc.
1.02%171.971.1%$507.80m
CELGCelgene Corporation
0.82%108.790.8%$480.49m
MDVNMedivation, Inc.
0.14%80.351.5%$457.05m
REGNRegeneron Pharmaceuticals, Inc.
0.68%402.973.4%$311.23m
ILMNIllumina, Inc.
1.61%172.214.2%$212.71m
ALXNAlexion Pharmaceuticals, Inc.
0.36%129.632.7%$186.81m
BMRNBioMarin Pharmaceutical Inc.
1.32%96.224.2%$183.84m
VRTXVertex Pharmaceuticals Incorporated
0.74%97.092.2%$112.19m
INCYIncyte Corporation
1.17%81.042.5%$106.31m
IONSIonis Pharmaceuticals, Inc.
1.75%30.9011.4%$96.76m
AAgilent Technologies, Inc.
0.13%47.320.9%$93.68m
TSROTESARO, Inc.
1.44%86.4616.2%$88.66m
EXASExact Sciences Corporation
0.74%19.1922.9%$86.20m

Company Profile

Hemispherx Biopharma, Inc. is a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and the experimental immunotherapeutic/antiviral Ampligen. Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Ampligen includes application as a treatment for Chronic Fatigue Syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.